Close

Trevi Therapeutics to Report Q4 and Year End 2020 Financial Results on March 25

Go back to Trevi Therapeutics to Report Q4 and Year End 2020 Financial Results on March 25
(NASDAQ: TRVI) Delayed: 2.58 -0.08 (3.01%)
Previous Close $2.66    52 Week High
Open $2.67    52 Week Low
Day High $2.67    P/E N/A 
Day Low $2.35    EPS
Volume 249,893